Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABBV-295 in Adults With Obesity or Overweight
NCT07752979Phase 2Recruiting
- Sponsor
- AbbVie Inc.
- Start
- Aug 2026
- Primary completion
- Mar 2028
- Countries
- 2
01
Overview
A Phase 2 trial of GUB014295 in obesity, sponsored by AbbVie Inc.. Started Aug 2026; status: recruiting.
02
Drugs
GUB014295
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07752979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07752979.